Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Head & Neck 1Gynecologic 1Genitourinary 1Breast 1

Conditions

Thyroid Neoplasms 17Squamous Cell Carcinoma of Head and Neck 8Thyroid Carcinoma, Anaplastic 5Thyroid Cancer, Papillary 3Endometrial Neoplasms 3Adenocarcinoma, Follicular 3Triple Negative Breast Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Ovarian Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Hepatocellular 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid cancer, medullary 1Thyroid cancer, Hurthle cell 1Thyroid Diseases 1Thyroid Cancer Metastatic 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Salivary Gland Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Melanoma 1Locally Advanced Thyroid Gland Carcinoma 1Head and Neck Neoplasms 1Gallbladder Neoplasms 1Esophageal Neoplasms 1Differentiated Thyroid Cancer (DTC) 1

Interventions

Trastuzumab 3Docetaxel 3Cisplatin 3pembrolizumab 2Nivolumab 2Gemcitabine 2Capecitabine 2Albumin-Bound Paclitaxel 2130-nm albumin-bound paclitaxel 2trastuzumab deruxtecan 1tipifarnib 1seribantumab 1sargramostim 1pertuzumab 1lenvatinib 1entinostat 1Thalidomide 1Taxes 1Specimen Handling 1Platinum 1Paclitaxel 1Oxaliplatin 1Magnetic Resonance Spectroscopy 1Irinotecan 1Ipilimumab 1Interleukin-12 Subunit p35 1Interleukin-12 1Immunohistochemistry 1Granulocyte-Macrophage Colony-Stimulating Factor 1Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gallbladder Neoplasms × lenvatinib × Head & Neck × Clear all
NCT05007106 2025-08-14

KEYVIBE-005

Merck Sharp & Dohme LLC

Phase 2 Completed
613 enrolled
BreastGastrointestinalGenitourinaryGynecologicHead & Neck

Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Ovarian Neoplasms, Stomach Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡